⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5552306 | 0.72 | — | — | |
| SCHEMBL7087563 | 0.70 | — | — | |
| SCHEMBL10811391 | 0.70 | — | — | |
| SCHEMBL2777128 | 0.70 | — | — | |
| SCHEMBL667596 | 0.65 | CYP2C19 (0.33) | — | |
| SCHEMBL7706446 | 0.63 | — | — | |
| SCHEMBL28048009 | 0.63 | — | — | |
| SCHEMBL16748023 | 0.63 | — | — | |
| SCHEMBL15415704 | 0.62 | — | — | |
| SCHEMBL7701588 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3021860-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | Leptrex Ltd. (GB) | 2016-05-25 | — | — | EP | claimed |
| WO-2015008019-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2015-01-22 | — | — | WO | claimed |
| WO-2014009759-A2 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2014-01-16 | — | — | WO | claimed |
| WO-2007089685-A2 | COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2007-08-09 | — | — | WO | claimed |
| WO-2006039285-A2 | COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2006-04-13 | — | — | WO | claimed |
| US-9707201-B2 | Allium extracts | LEPTREX LTD (GB) | 2017-07-18 | — | — | US | disclosed |
| US-20160151324-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2016-06-02 | — | — | US | disclosed |
| EP-3021860-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | Leptrex Ltd. (GB) | 2016-05-25 | — | — | EP | disclosed |
| EP-2872590-A1 | METAL COMPLEXES | Merck Patent GmbH (DE) | 2015-05-20 | — | — | EP | disclosed |
| WO-2015008019-A1 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2015-01-22 | — | — | WO | disclosed |
| WO-2014009759-A2 | IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS | LEPTREX LTD (GB) | 2014-01-16 | — | — | WO | disclosed |
| WO-2014008982-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2014-01-16 | — | — | WO | disclosed |
| WO-2007089685-A2 | COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2007-08-09 | — | — | WO | disclosed |
| WO-2006039285-A2 | COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2006-04-13 | — | — | WO | disclosed |
| WO-2003075901-A2 | USE OF S-SUBSTITUTED L-CRYSTEINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | GHISALBERTI CARLO (BR) | 2003-09-18 | — | — | WO | disclosed |
| US-4643994-A | ANTICOAGULANTS, ANTIBIOTICS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1987-02-17 | — | — | US | disclosed |
| EP-0185324-A2 | Novel organic trithio oxides and method for the preparation thereof | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1986-06-25 | — | — | EP | disclosed |